The Asia Pacific Mental Health Screening Market would witness market growth of 13.3% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Mental Health Screening Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $164.6 million by 2031. The Japan market is showcasing a CAGR of 12.6% during (2024 - 2031). Additionally, The India market would register a CAGR of 14% during (2024 - 2031).
A greater recognition of the significance of mental health to overall well-being has propelled workplace mental health programs to gain considerable traction in recent years. Many employers are becoming aware of the correlation between employee engagement, productivity, organizational performance, and mental health.
Moreover, one key aspect of workplace mental health programs is integrating mental health screening programs as part of broader employee wellness initiatives. Employees whom these screening programs identify as potentially afflicted with mental health conditions such as anxiety, depression, or stress may be so much more.
The expanding mental health screening market in Asia-Pacific is driven by the region's significant burden of mental health conditions and the need to address large treatment gaps. According to the World Health Organization (WHO), approximately 260 million people in the WHO South-East Asia Region alone live with mental health conditions, underscoring the scale of the challenge.
Based on Age Group, the market is segmented into Adults (age 19-64 years), Children & Adolescents (age 0-18 years), and Seniors (age 65 and above). Based on Setting, the market is segmented into Clinical Settings, Educational Institutions & Others, and Workplace/Corporate Programs & Online Platforms. Based on Technology, the market is segmented into Telehealth & Virtual Care Solutions, Self-screening mHealth Apps, AI-based Screening Tools, and Continuous Monitoring Wearable Devices & Others. Based on Screening Method, the market is segmented into Self-reported Questionnaires & Surveys, Clinical Interviews, Observation-based Assessments, and Biomarker Testing. Based on Application, the market is segmented into Physiological Disorders (Depression & Anxiety, Eating Disorder, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, and Others), Psychiatric Disorders (Attention Deficit Hyperactivity Disorder (ADHD), Psychotic Disorder, Dissociative Disorder, Obsessive Compulsive Disorder, Schizophrenia, and Others), Cognitive Disorders (Cognitive Impairment, Dementia, and Alzheimer's Disease & Others), and Behavioral Disorders (Self-Harm, Aggression, Sleep Disorder, Social Withdrawal, Dissociative Disorder, Hyperactivity, and Others).Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Mental Health Screening Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $164.6 million by 2031. The Japan market is showcasing a CAGR of 12.6% during (2024 - 2031). Additionally, The India market would register a CAGR of 14% during (2024 - 2031).
A greater recognition of the significance of mental health to overall well-being has propelled workplace mental health programs to gain considerable traction in recent years. Many employers are becoming aware of the correlation between employee engagement, productivity, organizational performance, and mental health.
Moreover, one key aspect of workplace mental health programs is integrating mental health screening programs as part of broader employee wellness initiatives. Employees whom these screening programs identify as potentially afflicted with mental health conditions such as anxiety, depression, or stress may be so much more.
The expanding mental health screening market in Asia-Pacific is driven by the region's significant burden of mental health conditions and the need to address large treatment gaps. According to the World Health Organization (WHO), approximately 260 million people in the WHO South-East Asia Region alone live with mental health conditions, underscoring the scale of the challenge.
Based on Age Group, the market is segmented into Adults (age 19-64 years), Children & Adolescents (age 0-18 years), and Seniors (age 65 and above). Based on Setting, the market is segmented into Clinical Settings, Educational Institutions & Others, and Workplace/Corporate Programs & Online Platforms. Based on Technology, the market is segmented into Telehealth & Virtual Care Solutions, Self-screening mHealth Apps, AI-based Screening Tools, and Continuous Monitoring Wearable Devices & Others. Based on Screening Method, the market is segmented into Self-reported Questionnaires & Surveys, Clinical Interviews, Observation-based Assessments, and Biomarker Testing. Based on Application, the market is segmented into Physiological Disorders (Depression & Anxiety, Eating Disorder, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, and Others), Psychiatric Disorders (Attention Deficit Hyperactivity Disorder (ADHD), Psychotic Disorder, Dissociative Disorder, Obsessive Compulsive Disorder, Schizophrenia, and Others), Cognitive Disorders (Cognitive Impairment, Dementia, and Alzheimer's Disease & Others), and Behavioral Disorders (Self-Harm, Aggression, Sleep Disorder, Social Withdrawal, Dissociative Disorder, Hyperactivity, and Others).Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Proem Heath, Inc.
- SonderMind, Inc
- ResMed, Inc.
- Headspace, Inc.
- Quartet Inc.
- Fitbit, Inc. (Google LLC)
- Sonde Health, Inc. (Puretech Health Plc)
- Koninklijke Philips N.V
- Apple, Inc
- Canary Speech, Inc
Market Report Segmentation
By Age Group- Adults (age 19-64 years)
- Children & Adolescents (age 0-18 years)
- Seniors (age 65 and above)
- Clinical Settings
- Educational Institutions & Others
- Workplace/Corporate Programs & Online Platforms
- Telehealth & Virtual Care Solutions
- Self-screening mHealth Apps
- AI-based Screening Tools
- Continuous Monitoring Wearable Devices & Others
- Self-reported Questionnaires & Surveys
- Clinical Interviews
- Observation-based Assessments
- Biomarker Testing
- Physiological Disorders
- Depression & Anxiety
- Eating Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Bipolar Disorder
- Others
- Psychiatric Disorders
- Attention Deficit Hyperactivity Disorder (ADHD)
- Psychotic Disorder
- Dissociative Disorder
- Obsessive Compulsive Disorder
- Schizophrenia
- Others
- Cognitive Disorders
- Cognitive Impairment
- Dementia
- Alzheimer's Disease & Others
- Behavioral Disorders
- Self-Harm
- Aggression
- Sleep Disorder
- Social Withdrawal
- Dissociative Disorder
- Hyperactivity
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Asia Pacific Mental Health Screening Market by Age Group
Chapter 6. Asia Pacific Mental Health Screening Market by Setting
Chapter 7. Asia Pacific Mental Health Screening Market by Technology
Chapter 8. Asia Pacific Mental Health Screening Market by Screening Method
Chapter 9. Asia Pacific Mental Health Screening Market by Application
Chapter 10. Asia Pacific Mental Health Screening Market by Country
Chapter 11. Company Profiles
Companies Mentioned
- Proem Heath, Inc.
- SonderMind, Inc
- ResMed, Inc.
- Headspace, Inc.
- Quartet Inc.
- Fitbit, Inc. (Google LLC)
- Sonde Health, Inc. (Puretech Health Plc)
- Koninklijke Philips N.V
- Apple, Inc
- Canary Speech, Inc
Methodology
LOADING...
